Jayne B. Hart - Oct 9, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief People Officer
Signature
By: Nathan A. Smith For: Jayne B. Hart
Stock symbol
MYGN
Transactions as of
Oct 9, 2021
Transactions value $
-$152,115
Form type
4
Date filed
10/12/2021, 04:42 PM
Previous filing
Sep 27, 2021
Next filing
Dec 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Tax liability -$61.1K -1.98K -1.31% $30.88 149K Oct 9, 2021 Direct F1, F2
transaction MYGN Common Stock Tax liability -$91K -2.95K -1.98% $30.88 146K Oct 9, 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.
F2 Includes 41,021 shares of Myriad common stock that were omitted from the reporting person's Form 3, which was amended to reflect such shares on October 12, 2021.
F3 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021.